SwePub
Sök i LIBRIS databas

  Utökad sökning

id:"swepub:oai:DiVA.org:oru-79795"
 

Sökning: id:"swepub:oai:DiVA.org:oru-79795" > Risk factors for lo...

  • Valachis, Antonios,1984-Uppsala universitet,Experimentell och klinisk onkologi,Centrum för klinisk forskning i Sörmland (CKFD) (författare)

Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy : An international collaboration and individual patient meta-analysis

  • Artikel/kapitelEngelska2018

Förlag, utgivningsår, omfång ...

  • 2018-05-03
  • John Wiley & Sons,2018
  • printrdacarrier

Nummerbeteckningar

  • LIBRIS-ID:oai:DiVA.org:oru-79795
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-79795URI
  • https://doi.org/10.1002/cncr.31518DOI
  • https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-361268URI

Kompletterande språkuppgifter

  • Språk:engelska
  • Sammanfattning på:engelska

Ingår i deldatabas

Klassifikation

  • Ämneskategori:ref swepub-contenttype
  • Ämneskategori:art swepub-publicationtype

Anmärkningar

  • BACKGROUND: Several studies have reported a high risk of local disease recurrence (LR) and locoregional disease recurrence (LRR) in patients with breast cancer after neoadjuvant chemotherapy (NCT) and breast-conserving therapy (BCT). The objective of the current study was to identify potential risk factors for LR and LRR after NCT and BCT.METHODS: Individual patient data sets from 9 studies were pooled. The outcomes of interest were the occurrence of LR and/or LRR. A 1-stage meta-analytic approach was used. Cox proportional hazards regression models were applied to identify factors that were predictive of LR and LRR, respectively.RESULTS: A total of 9 studies (4125 patients) provided their data sets. The 10-year LR rate was 6.5%, whereas the 10-year LRR rate was 10.3%. Four factors were found to be associated with a higher risk of LR: 1) estrogen receptor-negative disease; 2) cN + disease; 3) a lack of pathologic complete response in axilla (pN0); and 4) pN2 to pN3 disease. The predictive score for LR determined 3 risk groups: a low-risk, intermediate-risk, and high-risk group with 10-year LR rates of 4.0%, 7.9%, and 20.4%, respectively. Two additional factors were found to be associated with an increased risk of LRR: cT3 to cT4 disease and a lack of pathologic complete response in the breast. The predictive score for LRR determined 3 risk groups; a low-risk, intermediate-risk, and high-risk group with 10-year LRR rates of 3.2%, 10.1%, and 24.1%, respectively.CONCLUSIONS: BCT after NCT appears to be an oncologically safe procedure for a large percentage of patients with breast cancer. Two easy-to-use clinical scores were developed that can help clinicians to identify patients at higher risk of LR and LRR after NCT and BCT and individualize the postoperative treatment plan and follow-up.

Ämnesord och genrebeteckningar

Biuppslag (personer, institutioner, konferenser, titlar ...)

  • Mamounas, Eleftherios P.Comprehensive Breast Program, University of Florida Health Cancer Center‐Orlando Health, Orlando, Florida,Univ Florida, Hlth Canc Ctr Orlando Hlth, Comprehens Breast Program, Orlando, FL USA (författare)
  • Mittendorf, Elizabeth A.Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas,Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA (författare)
  • Hayashi, NaokiDepartment of Breast Surgery, St. Luke's International Hospital, Tokyo, Japan,St Lukes Int Hosp, Dept Breast Surg, Tokyo, Japan (författare)
  • Ishitobi, MakotoDepartment of Breast Surgery, Osaka International Cancer Institute, Osaka, Japan; Department of Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan,Osaka Int Canc Inst, Dept Breast Surg, Osaka, Japan;Osaka Int Canc Inst, Dept Endocrine Surg, Osaka, Japan (författare)
  • Natoli, ClaraDepartment of Oral, Medical and Biotechnological Sciences, University G. D'Annunzio, Chieti‐Pescara, Italy,Univ G DAnnunzio, Dept Oral Med & Biotechnol Sci, Chieti, Italy (författare)
  • Fitzal, FlorianDepartment of Surgery, Breast Health Center, Medical University Vienna, Vienna, Austria,Med Univ Vienna, Dept Surg, Breast Hlth Ctr, Vienna, Austria (författare)
  • Rubio, Isabel T.Breast Surgical Oncology, Breast Cancer Center, University Hospital VAll d'Hebron, Barcelona, Spain,Univ Hosp VAll dHebron, Breast Canc Ctr, Breast Surg Oncol, Barcelona, Spain (författare)
  • Tiezzi, Daniel G.Breast Disease Division, Department of Gynecology and Obstetrics, Ribeirao Preto Medical School, University of Sao Paulo, Sao Paulo, Brazil,Univ Sao Paulo, Ribeirao Preto Med Sch, Breast Dis Div, Dept Gynecol & Obstet, Sao Paulo, Brazil (författare)
  • Shin, Hee-ChulDepartment of Surgery, Chung‐Ang University Hospital, Seoul, South Korea,Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea (författare)
  • Anderson, Stewart J.National Surgical Adjuvant Breast and Bowel Project Biostatistical Center, Department of Biostatistics, University of Pittsburgh Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania,Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Natl Surg Adjuvant Breast & Bowel Project,Biostat, Pittsburgh, PA 15261 USA (författare)
  • Hunt, Kelly K.Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas,Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA (författare)
  • Matsuda, NaokoDepartment of Breast Surgery, St. Luke's International Hospital, Tokyo, Japan,St Lukes Int Hosp, Dept Breast Surg, Tokyo, Japan (författare)
  • Ohsumi, ShozoDepartment of Breast Oncology, NHO Shikoku Cancer Center, Matsuyama, Japan,NHO Shikoku Canc Ctr, Dept Breast Oncol, Matsuyama, Ehime, Japan (författare)
  • Totomi, AthinaUppsala universitet,Centrum för klinisk forskning i Sörmland (CKFD) (författare)
  • Nilsson, CeciliaCentre for Clinical Research, Vastmanlands County Hospital, Vasteras, Sweden,Vastmanlands Cty Hosp, Ctr Clin Res, Vasteras, Sweden (författare)
  • Uppsala universitetExperimentell och klinisk onkologi (creator_code:org_t)

Sammanhörande titlar

  • Ingår i:Cancer: John Wiley & Sons124:14, s. 2923-29300008-543X1097-0142

Internetlänk

Hitta via bibliotek

  • Cancer (Sök värdpublikationen i LIBRIS)

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy